We Should All Be Science Critics
By John Horgan,
Scientific American
| 08. 05. 2019
A while back my school, Stevens Institute of Technology, created a new major called science and technology studies, or STS. It seemed a little amorphous, but I felt an affinity for it. Also, I’ve liked pretty much every STS scholar I’ve met. They are a diverse bunch, both in personality and interests, but they all grapple with compelling issues, ranging from allergies and pharmaceuticals to marine biology and nuclear weapons (and that's just at Stevens). One of the most impressive STS scholars I've met is a pioneer of the field, Sheila Jasanoff. Born and raised in India (Jasanoff is her husband’s name), she ended up at Harvard, where she earned a bachelor’s in mathematics, law degree and doctorate in linguistics. After founding an STS program at Cornell, she returned to Harvard to create its STS program, which she oversees. Jasanoff is an imposing woman, a force of nature wrapped in a sari. She has thought especially hard--and written many articles and books--about the role of science and technology in a democracy. The time seems right to ask her a few questions. – John Horgan...
Related Articles
By Jason Liebowitz, The New Yorker | 03.06.2026
When Talaya Reid was in high school, in a quiet suburb of Philadelphia, she developed fatigue so severe that she spent afternoons napping instead of going out with friends. She was lethargic at school and her grades suffered, but after...
By Scott Solomon, The MIT Press Reader | 02.12.2026
Chris Mason is a man in a hurry.
“Sometimes walking from the subway to the lab takes too long, so I’ll start running,” he told me over breakfast at a bistro near his home in Brooklyn on a crisp...
By Diaa Hadid and Shweta Desai, NPR | 01.29.2026
MUMBRA, India — The afternoon sun shines on the woman in a commuter-town café, highlighting her almond-shaped eyes and pale skin, a look often sought after by couples who need an egg to have a baby.
"I have good eggs,"...
By George Janes, BioNews | 01.12.2026
A heart attack patient has become the first person to be treated in a clinical trial of an experimental gene therapy, which aims to strengthen blood vessels after coronary bypass surgery.
Coronary artery bypass surgery is performed to treat...